A Study Evaluating Outcomes Of Ledipasvir-Sofosbuvir (Harvoni) For Hepatitis C Virus Infection In Non-Transplant Patients At A Diverse, Urban, Tertiary Center Clinical Setting
Latest Information Update: 26 May 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017.